Today: 20 March 2026
Browse Category

Mining Industry 27 February 2026 - 18 March 2026

B2Gold Corp. Stock Falls Nearly 5% as Gold Slips Below $5,000 and Goose Risks Return

B2Gold Corp. Stock Falls Nearly 5% as Gold Slips Below $5,000 and Goose Risks Return

B2Gold shares fell nearly 5% Wednesday as gold dropped below $5,000 an ounce after the Federal Reserve held rates steady and warned on inflation. The miner’s 2026 cost outlook is based on gold at $5,000, but spot gold slid 2.9% to $4,860.21. B2Gold expects lower 2026 output, with most Goose mine production coming later in the year. Founder Clive Johnson will step down as CEO on June 4.
Why Denison Mines Stock Price Is Rising as Phoenix Uranium Mine Nears Construction

Why Denison Mines Stock Price Is Rising as Phoenix Uranium Mine Nears Construction

Denison Mines shares rose 1.2% to $3.705 Tuesday after announcing it will begin site preparation at its Phoenix uranium project in Saskatchewan this month, following final federal approval in February. Phoenix is the first Canadian uranium mine to secure federal construction approval in over 20 years. Trading volume topped 25 million shares. Denison targets first production by mid-2028 and has US$345 million in convertible notes to help fund construction.
Vale Stock Price Today: Shares Fall Despite Iron Ore-From-Waste Milestone

Vale Stock Price Today: Shares Fall Despite Iron Ore-From-Waste Milestone

Vale’s U.S.-listed shares fell 2.5% to $14.68 Friday after RBC downgraded the stock, citing valuation concerns despite strong operational updates. The company more than doubled iron ore recovered from waste in 2025, reaching 26.3 million tons. Vale’s 2025 output hit 336.1 million tons, its highest since 2018. RBC now sees Vale’s 2026 dividend yield at about 8%, but no longer expects further upside.
Why B2Gold Stock Price Is Falling Today as Goose Ramp-Up Risks Return

Why B2Gold Stock Price Is Falling Today as Goose Ramp-Up Risks Return

B2Gold shares dropped nearly 5% Friday as gold prices slid and its annual report highlighted execution risks at the Goose mine in Nunavut. The company forecast 2026 production of up to 970,000 ounces, down from 2025, with costs rising to as much as $2,580 an ounce. Goose’s output is weighted to late 2026, with full ramp-up not expected until 2027. B2Gold reported 2025 gold revenue of $3.06 billion and net income of $427 million.
Anglo American Stock Price Slides 2% as $100 Oil Hammers London Miners

Anglo American Stock Price Slides 2% as $100 Oil Hammers London Miners

Anglo American shares dropped about 2% to 3,188 pence Friday, tracking a wider 2.1% fall in London’s mining index as oil prices stayed above $100 a barrel and rate-cut hopes faded. The stock traded nearly 18% below its Feb. 25 high, pressured by ex-dividend trading, lower copper guidance, De Beers losses, and uncertainty over the planned $53 billion Teck merger.
Denison Mines stock slips after 2025 results as Phoenix mine start nears

Denison Mines stock slips after 2025 results as Phoenix mine start nears

Denison Mines shares fell 1.6% to $3.98 after reporting a C$217.3 million net loss for 2025 and confirming construction of its Phoenix uranium project in Saskatchewan will start this month. Phoenix received final federal approval in February and targets first production by mid-2028. Denison reported C$465.9 million in cash at year-end and an upfront US$6 million uranium sales deal. Uranium sector stocks were mixed in New York trading.
Australia Stock Market Today: ASX 200 Suffers Worst Day in 11 Months as Oil Shock Slams Miners and Financials

Australia Stock Market Today: ASX 200 Suffers Worst Day in 11 Months as Oil Shock Slams Miners and Financials

Australia’s S&P/ASX 200 fell 2.85% to 8,599 on Monday, its worst day in 11 months, after Brent crude surged up to 25% to $119.50 a barrel amid escalating conflict in the Middle East. Materials and tech stocks led losses, while energy shares gained. Bond yields jumped to multi-year highs. G7 ministers plan to discuss emergency oil reserves as investors brace for further volatility.
Denison Mines Corp Sets March Start for Phoenix Uranium Mine as Canada Readies Nuclear Strategy

Denison Mines Corp Sets March Start for Phoenix Uranium Mine as Canada Readies Nuclear Strategy

Denison Mines’ board has approved construction of the Phoenix in-situ recovery uranium mine, with site work set to begin in March 2026. The project, cleared by Canadian regulators in February, is Canada’s first uranium mine to use the ISR method. Denison estimates a C$600 million capital cost and targets first production by mid-2028, but warns of possible delays and cost increases. NexGen’s Rook I project also secured final federal approval this week.
Anglo American CEO sells shares as 2023 incentive plan vests at 21.2%

Anglo American CEO sells shares as 2023 incentive plan vests at 21.2%

Anglo American CEO Duncan Wanblad sold 24,074 shares at £36.384 each to cover taxes after incentive awards vested, according to a regulatory filing. The company’s 2023 long-term incentive plan vested at 21.2% of the maximum, with most retained shares under a two-year lock-up. The disclosure comes as Anglo pursues a merger with Teck and reviews its executive pay structure. The Teck deal still awaits some regulatory approvals.
Malaysia steps in to calm Lynas fears after US minerals deals — what changes and what doesn’t

Malaysia steps in to calm Lynas fears after US minerals deals — what changes and what doesn’t

Malaysia’s trade ministry said U.S. trade and critical minerals agreements will not change technical conditions imposed on Lynas Malaysia’s rare-earth operations. The ministry confirmed Lynas’ 10-year licence renewal remains subject to waste management rules. Talks between state investor Khazanah and Chinese firms on rare-earth projects are still in early stages. No final deals have been reached.
5 March 2026
Glencore share price today: GLEN steadies as Jefferies backs miners amid Iran war jitters

Glencore share price today: GLEN steadies as Jefferies backs miners amid Iran war jitters

Glencore shares rose 0.1% to 527.0 pence in early London trading Wednesday after a sharp market pullback. Analysts cited the Iran conflict and surging energy prices as drivers for commodity stocks, with Jefferies noting potential supply risks for metals. The FTSE 100 fell 2.8% Tuesday as traders trimmed bets on a Bank of England rate cut. Investors remain focused on energy prices and UK monetary policy signals.
BHP stock tumbles as miners slide and dividend deadlines loom — what to watch next

BHP stock tumbles as miners slide and dividend deadlines loom — what to watch next

BHP’s U.S.-listed shares fell 5.6% to $78.33 late Tuesday, tracking declines in Rio Tinto and Vale. The drop comes as BHP’s interim dividend of 73 cents a share approaches its March 6 ex-dividend date in New York. A March 2 filing set an ASX ex-date of March 5 and detailed South African rand conversion. Investors are watching rate signals and geopolitical risks as dividend season continues.
Glencore share price slides 3% as war-driven oil shock hits London miners — what’s next for GLEN stock

Glencore share price slides 3% as war-driven oil shock hits London miners — what’s next for GLEN stock

Glencore shares fell 3.2% to 517.1 pence in early London trading Tuesday, reversing from a 12-month high. Rio Tinto, BHP, and Anglo American also declined as European stocks dropped on renewed Middle East tensions and rising oil prices. The STOXX 600 slipped 1.3% after Iran said the Strait of Hormuz was closed to marine traffic. Investors are watching inflation signals and Glencore’s April 30 production update.
Rio Tinto stock drops 2% in London as war jitters bite; investors eye what’s next

Rio Tinto stock drops 2% in London as war jitters bite; investors eye what’s next

Rio Tinto shares dropped 2.1% to 7,181 pence in early London trading Tuesday, tracking losses across European miners as Middle East tensions drive up energy costs. The company approved a $473 million restart of its Richards Bay mineral sands project in South Africa and secured C$18.95 million in Canadian government support for a gallium pilot plant. Oil shipping costs surged as traffic through the Strait of Hormuz slowed.
Sunrise Energy Metals share price slips after feasibility study update puts ASX:SRL back in play

Sunrise Energy Metals share price slips after feasibility study update puts ASX:SRL back in play

Sunrise Energy Metals shares fell 3.6% to A$7.69 after the company released a feasibility study update for its Syerston scandium project and trading resumed. The study put development capital at about US$120 million, with commercial production targeted for mid-2028. Investors await a funding package and a board decision expected in the second half of 2026. The stock is down 29% over the past week.
PLS Group (ASX:PLS) share price pulls back after lithium shock from Zimbabwe

PLS Group (ASX:PLS) share price pulls back after lithium shock from Zimbabwe

PLS Group shares fell 1.1% to A$5.19 on Friday, retracing part of Thursday’s 8.3% jump. The decline followed Zimbabwe’s immediate suspension of raw mineral and lithium concentrate exports, which triggered supply concerns. China’s lithium carbonate futures surged over 6% after the ban. Zimbabwe exported over 1.1 million metric tons of lithium-bearing concentrate to China in 2025.
1 2 3 28

Stock Market Today

  • Ocugen Outlook: Late-Stage Catalysts vs Cash Burn and Dilution Risks
    March 20, 2026, 9:34 AM EDT. Ocugen OCGN faces a critical phase with multiple late-stage clinical readouts across three ocular gene therapy programs slated for 2026-27, creating potential volatile stock swings based on clinical and regulatory outcomes. The company reported a $67.8 million net loss in fiscal 2025, driven by high research and pre-commercialization costs typical of late-stage biotech development. Cash on hand stood at $18.9 million, bolstered by a $22.5 million direct offering in early 2026, extending the cash runway to late 2026. However, with no commercial approvals expected before 2027, Ocugen may face dilution risks unless it secures additional funding or non-dilutive resources. Revenue remains modest, primarily from a CanSinoBIO collaboration, highlighting the company's reliance on pipeline progress to shape its financial outlook and investor sentiment.
Go toTop